2/26/2021 9:04:10 AM
Amgen And AZN: Tezepelumab To Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
2/22/2021 2:09:00 AM
AstraZeneca Announces Voluntary Withdrawal Of Imfinzi Indication In Advanced Bladder Cancer In US
2/17/2021 2:12:04 AM
AstraZeneca Says OlympiA Phase III Trial And MSD's Lynparza Will Move To Early Primary Analysis
2/16/2021 9:02:30 AM
AliveCor Collaborates With AstraZeneca To Develop Non-Invasive Potassium Monitoring Solutions
2/11/2021 2:06:31 AM
AstraZeneca: Non-Executive Directors Geneviève Berger And Graham Chipchase To Retire From Board At AGM
2/11/2021 2:02:38 AM
AstraZeneca Q4 Core EPS $1.07; Reported EPS $0.78
2/10/2021 2:03:57 AM
AstraZeneca Completes Divestment Of Rights To Crestor In Europe To Grünenthal GmbH
2/5/2021 2:06:37 AM
AstraZeneca Issues Update On KESTREL Phase III Trial Of Imfinzi With Or Without Tremelimumab